1Vissers, LELM, Gilissen, C, Veltman, JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet 2015; 17: 9–18.
2Malhotra, D, Sebat, J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012; 148: 1223–41.
3Redon, R, Ishikawa, S, Fitch, KR, Feuk, L, Perry, GH, Andrews, TD, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444–54.
4Marshall, CR, Howrigan, DP, Merico, D, Thiruvahindrapuram, B, Wu, W, Greer, DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet 2017; 49: 27–35.
5Sanders, S, Ercan-Sencicek, AG, Hus, V, Luo, R, Murtha, MT, Moreno-De-Luca, D, et al. Multiple recurrent de novo copy number variations (CNVs), including duplications of the 7q11.23 Williams-Beuren syndrome region, are strongly associated with autism. Neuron 2011; 70: 863–85.
6Coe, BP, Witherspoon, K, Rosenfeld, JA, van Bon, BWM, Vulto-van Silfhout, AT, Bosco, P, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet 2014; 46: 1063–71.
7Rees, E, Kendall, K, Pardiñas, AF, Legge, SE, Pocklington, A, Escott-Price, V, et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 2016; 73: 963–9.
8Vorstman, JAS, Parr, JR, Moreno-De-Luca, D, Anney, RJL, Nurnberger, JI, Hallmayer, JF. Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet 2017; 18: 362–76.
9Palmer, E, Speirs, H, Taylor, PJ, Mullan, G, Turner, G, Einfeld, S, et al. Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability. Am J Med Genet A 2014; 164: 377–85.
10Miller, DT, Adam, MP, Aradhya, S, Biesecker, LG, Brothman, AR, Carter, NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749–64.
11World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
12American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder (4th edn) (DSM-IV). APA, 1994.
13Kearney, HM, Thorland, EC, Brown, KK, Quintero-Rivera, F, South, ST. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011; 13: 680–5.
15Kendall, KM, Rees, E, Escott-Price, V, Einon, M, Thomas, R, Hewitt, J, et al. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK biobank subjects. Biol Psychiatry 2017; 82: 103–10.
16Perneger, TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236–8.
17Rothman, KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43–6.
18R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2013.
19Wolfe, K, Strydom, A, Morrogh, D, Carter, J, Cutajar, P, Eyeoyibo, M, et al. Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders. Eur J Hum Genet 2016; 25: 66–72.
20Zuko, A, Kleijer, KTE, Oguro-ando, A, Kas, MJH, Daalen, EV, Zwaag, BVD, et al. Contactins in the neurobiology of autism. Eur J Pharmacol 2013; 719: 63–74.
21Pinto, D, Pagnamenta, AT, Klei, L, Anney, R, Merico, D, Regan, R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368–72.
22Daalen, EV, Kemner, C, Verbeek, NE, Zwaag, BVD, Burbach, JPH, Kristian, H, et al. Social responsiveness scale-aided analysis of the clinical impact of copy number variations in autism. Neurogenetics 2011; 12: 315–23.
23Kashevarova, AA, Nazarenko, LP, Schultz-Pedersen, S, Skryabin, NA, Salyukova, OA, Chechetkina, NN, et al. Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability. Mol Cytogenet 2014; 7: 97.
24Hu, J, Liao, J, Sathanoori, M, Kochmar, S, Sebastian, J, Yatsenko, SA, et al. CNTN6 copy number variations in 14 patients: a possible candidate gene for neurodevelopmental and neuropsychiatric disorders. J Neurodev Disord 2015; 7: 26.
25Oguro-Ando, A, Zuko, A, Kleijer, KTE, Burbach, JPH. A current view on contactin-4, -5, and -6: implications in neurodevelopmental disorders. Mol Cell Neurosci 2017; 81: 72–83.
26Warnica, W, Merico, D, Costain, G, Alfred, SE, Wei, J, Marshall, CR, et al. Copy number variable micrornas in schizophrenia and their neurodevelopmental gene targets. Biol Psychiatry 2015; 77: 158–66.
27Zahir, F, Firth, HV, Baross, A, Delaney, AD, Eydoux, P, Gibson, WT, et al. Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children. J Med Genet 2007; 44: 556–61.
28Bernier, R, Golzio, C, Xiong, B, Stessman, Ha, Coe, BP, Penn, O, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 2014; 158: 263–76.
29Prontera, P, Ottaviani, V, Toccaceli, D, Rogaia, D, Ardisia, C, Romani, R, et al. Recurrent ~100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly. Am J Med Genet A 2014; 164: 3137–41.
30Smyk, M, Poluha, A, Jaszczuk, I, Bartnik, M, Bernaciak, J, Nowakowska, B. Novel 14q11.2 microduplication including the CHD8 and SUPT16H genes associated with developmental delay. Am J Med Genet A 2016; 170: 1325–9.
31Breckpot, J, Vercruyssen, M, Weyts, E, Vandevoort, S, D'Haenens, G, Van Buggenhout, G, et al. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. Eur J Med Genet 2016; 59: 436–43.
32Courage, C, Houge, G, Gallati, S, Schjelderup, J, Rieubland, C. 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity. Eur J Med Genet 2014; 57: 520–3.
33Chénier, S, Yoon, G, Argiropoulos, B, Lauzon, J, Laframboise, R, Ahn, J, et al. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. J Neurodev Disord 2014; 6: 9.
34Rees, E, Walters, JTR, Georgieva, L, Isles, AR, Chambert, KD, Richards, AL, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 2014; 204: 108–14.
35Baker, K, Costain, G, Fung, WLA, Bassett, AS. Chromosomal microarray analysis—a routine clinical genetic test for patients with schizophrenia. Lancet Psychiatry 2014; 1: 329–31.
36Habel, A, Herriot, R, Kumararatne, D, Allgrove, J, Baker, K, Baxendale, H, et al. Towards a safety net for management of 22q11.2 deletion syndrome: Guidelines for our times. Eur J Pediatr 2014; 173: 757–65.